C-RAD (CRAD) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
22 Oct, 2026Executive summary
Q3 order intake fell 29% YoY to MSEK 76 and revenue fell 24% to MSEK 85.4, amid weaker EMEA and APAC results and delayed customer decisions.
Services growth and a 76% gross margin partly offset lower product sales; the three-year transformation plan focuses on commercial conversion, recurring revenue and innovation.
Financial highlights
Q3 gross profit was MSEK 64.9, down 22% YoY; EBIT was MSEK 9.9, down 53%.
Q3 net earnings were MSEK 10.5 vs. MSEK 12.9; EPS was SEK 0.31 vs. SEK 0.38.
9M revenue decreased 7% to MSEK 311.8; EBIT rose 25% to MSEK 49.6 and net earnings increased to MSEK 45.8 from MSEK 8.8.
Excluding MSEK 10 in Q1 organizational-change one-offs, 9M EBIT was MSEK 59, with a 19% margin; net earnings were MSEK 54 and EPS was SEK 1.59.
9M operating cash flow was MSEK -7.7 vs. MSEK 50.5, mainly affected by MSEK 43.6 of tax paid, including tax relating to FY2024.
Outlook and guidance
Priorities into 2027 include improving commercial conversion in priority markets, growing recurring revenue from the installed base, and continuing product development and partnerships.
The three-year transformation targets a more customer-oriented, focused, scalable and innovation-driven business; progress was described as on plan, just over six months into the program.
Long-term targets are average organic growth above 10%, an EBIT margin of 25%, and returning at least 30% of net profit to shareholders, subject to investment needs and strategic considerations.
New platform-related products are expected to contribute revenue and order intake during 2027; management gave no formal revenue-growth guidance.
Latest events from C-RAD
- Strong growth in radiotherapy driven by rising cancer cases, recurring revenue, and strategic innovation.CRAD
Corporate presentation - Q2 2026 saw 16% revenue growth, 72% gross margin, and a completed restructuring program.CRAD
Q2 2026 - Order intake up 19% and gross margin at 73%, amid transformation and higher recurring revenue.CRAD
Q1 2026 - Q4 2025 order intake and revenue fell, but gross margin and cash rose; Americas outperformed.CRAD
Q4 2025 - Order intake up 11%, service orders up 86%, but revenue down 19% year-on-year.CRAD
Q2 2025 - Profitability held firm with improved margins, despite lower orders and EMEA weakness.CRAD
Q3 2024 - Q2 revenue up 43% and EBIT more than doubled, with strong APAC and Americas growth and margin boost from proton orders.CRAD
Q2 2024 - Adjusted EBIT margin reached 18% as service growth offset market and currency headwinds.CRAD
Q1 2025 - Q4 order intake up 13%, EBIT margin 17%, and APAC revenue up 112% amid global SGRT growth.CRAD
Q4 2024